📣 VC round data is live. Check it out!
- Public Comps
- Double Medical Technology
Double Medical Technology Valuation Multiples
Discover revenue and EBITDA valuation multiples for Double Medical Technology and similar public comparables like Insight Lifetech, Tecan Group, Sinbon Electronics, TransMedics and more.
Double Medical Technology Overview
About Double Medical Technology
Double Medical Technology Inc provides services and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery. It offers product related to Trauma, Spinal and joint. The business activities are carried out through China.
Founded
2004
HQ

Employees
N/A
Website
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialDouble Medical Technology Financials
Double Medical Technology reported last 12-month revenue of $407M and EBITDA of $164M.
In the same LTM period, Double Medical Technology generated $289M in gross profit, $164M in EBITDA, and $94M in net income.
Revenue (LTM)
Double Medical Technology P&L
In the most recent fiscal year, Double Medical Technology reported revenue of $384M and EBITDA of $139M.
Double Medical Technology is profitable as of last fiscal year, with gross margin of 71%, EBITDA margin of 36%, and net margin of 23%.
Financial data powered by Morningstar, Inc.
Double Medical Technology Stock Performance
Double Medical Technology has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Double Medical Technology's stock price is $6.03.
Double Medical Technology share price increased by 0.7% in the last 30 days, and by 14.5% in the last year.
Double Medical Technology has an EPS (earnings per share) of $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.1% | 0.7% | -6.1% | 14.5% | $0.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDouble Medical Technology Valuation Multiples
Double Medical Technology trades at 5.6x EV/Revenue multiple, and 13.9x EV/EBITDA.
EV / Revenue (LTM)
Double Medical Technology Financial Valuation Multiples
As of June 3, 2026, Double Medical Technology has market cap of $2B and EV of $2B.
Double Medical Technology has a P/E ratio of 26.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Double Medical Technology Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Double Medical Technology Margins & Growth Rates
Double Medical Technology grew revenue by 15% and EBITDA by 42% in the last fiscal year.
In the most recent fiscal year, Double Medical Technology reported gross margin of 71%, EBITDA margin of 36%, and net margin of 23%.
Double Medical Technology Margins
Double Medical Technology Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Double Medical Technology Operational KPIs
Double Medical Technology's Rule of 40 is 60% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Double Medical Technology's Rule of X is 83% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Double Medical Technology Competitors
Double Medical Technology competitors include Insight Lifetech, Tecan Group, Sinbon Electronics, TransMedics, Carl Zeiss Meditec, Ambu, Autobio Diagnostics, Elekta, GN Store Nord and Jeol.
Most Double Medical Technology public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 29.2x | - | 131.6x | - | |||
| 2.1x | 2.1x | 14.0x | 13.9x | |||
| 2.3x | 2.3x | 15.9x | 17.6x | |||
| 4.6x | 4.2x | 17.0x | 17.4x | |||
| 1.1x | 1.1x | 6.5x | 7.4x | |||
| 2.8x | 2.7x | 14.6x | 14.7x | |||
| 4.1x | 4.0x | 10.1x | 10.3x | |||
| 1.5x | 1.5x | 11.4x | 10.8x | |||
This data is available for Pro users. Sign up to see all Double Medical Technology competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Double Medical Technology
| When was Double Medical Technology founded? | Double Medical Technology was founded in 2004. |
| Where is Double Medical Technology headquartered? | Double Medical Technology is headquartered in China. |
| Is Double Medical Technology publicly listed? | Yes, Double Medical Technology is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Double Medical Technology? | Double Medical Technology trades under 002901 ticker. |
| When did Double Medical Technology go public? | Double Medical Technology went public in 2017. |
| Who are competitors of Double Medical Technology? | Double Medical Technology main competitors include Insight Lifetech, Tecan Group, Sinbon Electronics, TransMedics, Carl Zeiss Meditec, Ambu, Autobio Diagnostics, Elekta, GN Store Nord, Jeol. |
| What is the current market cap of Double Medical Technology? | Double Medical Technology's current market cap is $2B. |
| What is the current revenue of Double Medical Technology? | Double Medical Technology's last 12 months revenue is $407M. |
| What is the current revenue growth of Double Medical Technology? | Double Medical Technology revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Double Medical Technology? | Current revenue multiple of Double Medical Technology is 5.6x. |
| What is the current EBITDA of Double Medical Technology? | Double Medical Technology's last 12 months EBITDA is $164M. |
| What is Double Medical Technology's EBITDA margin? | Double Medical Technology's last 12 months EBITDA margin is 40%. |
| What is the current EV/EBITDA multiple of Double Medical Technology? | Current EBITDA multiple of Double Medical Technology is 13.9x. |
| How many companies Double Medical Technology has acquired to date? | Double Medical Technology hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Double Medical Technology has invested to date? | Double Medical Technology hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Double Medical Technology
Lists including Double Medical Technology
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.